News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors

News & Investors

22. November 2023 - 11:09 (CEST)

Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Read more

30. October 2023 - 0:00 (CEST)

Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024

Read more

27. October 2023 - 13:45 (CEST)

Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Read more

18. October 2023 - 14:53 (CEST)

Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Read more

10. October 2023 - 0:00 (CEST)

Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023

Read more

10. October 2023 - 0:00 (CEST)

Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company’s Assets and Adjustment of Guidance for 2023

Read more